Does the cytokine adsorber CytoSorb® reduce vancomycin exposure in critically ill patients with sepsis or septic shock? a prospective observational study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2110-5820
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Does the cytokine adsorber CytoSorb® reduce vancomycin exposure in critically ill patients with sepsis or septic shock? a prospective observational study ; volume:12 ; number:1 ; day:23 ; month:5 ; year:2022 ; pages:1-8 ; date:12.2022
Annals of intensive care ; 12, Heft 1 (23.5.2022), 1-8, 12.2022
- Creator
-
Scharf, Christina
Weinelt, Ferdinand
Schroeder, Ines
Paal, Michael
Weigand, Michael
Zoller, Michael
Irlbeck, Michael
Kloft, Charlotte
Briegel, Josef
Liebchen, Uwe
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13613-022-01017-5
- URN
-
urn:nbn:de:101:1-2022072618504896152377
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Scharf, Christina
- Weinelt, Ferdinand
- Schroeder, Ines
- Paal, Michael
- Weigand, Michael
- Zoller, Michael
- Irlbeck, Michael
- Kloft, Charlotte
- Briegel, Josef
- Liebchen, Uwe
- SpringerLink (Online service)
Other Objects (12)
Hemoadsorption by CytoSorb in septic patients: a case series
No clinically relevant removal of meropenem by cytokine adsorber CytoSorb® in critically ill patients with sepsis or septic shock
Cytokine clearance with CytoSorb® during cardiac surgery: a pilot randomized controlled trial
Hemoadsorption with CytoSorb® and the early course of linezolid plasma concentration during septic shock
CytoSorb hemoperfusion markedly attenuates circulating cytokine concentrations during systemic inflammation in humans in vivo
Cytokine hemoadsorption with CytoSorb® in post-cardiac arrest syndrome, a pilot randomized controlled trial
Efficacy of CytoSorb®: a systematic review and meta-analysis
Analyse der Ulmer Datenbanken zum internationalen CytoSorb-Register: Dynamik der laborchemischen Leberparameter unter Anwendung des Hämadsorbers CytoSorb bei Patienten der herzchirurgischen Intensivstation
Can the cytokine adsorber CytoSorb® help to mitigate cytokine storm and reduce mortality in critically ill patients? A propensity score matching analysis
Datenerhebung und Auswertung zum internationalen CytoSorb-Register am Universitätsklinikum Ulm
CytoResc – “CytoSorb” Rescue for critically ill patients undergoing the COVID-19 Cytokine Storm: A structured summary of a study protocol for a randomized controlled trial
Prospektive Observationsstudie zur Anwendung von CytoSorb® bei Intensivpatienten mit akutem Leberversagen
Hemoadsorption by CytoSorb in septic patients: a case series
No clinically relevant removal of meropenem by cytokine adsorber CytoSorb® in critically ill patients with sepsis or septic shock
Cytokine clearance with CytoSorb® during cardiac surgery: a pilot randomized controlled trial
Hemoadsorption with CytoSorb® and the early course of linezolid plasma concentration during septic shock
CytoSorb hemoperfusion markedly attenuates circulating cytokine concentrations during systemic inflammation in humans in vivo
Cytokine hemoadsorption with CytoSorb® in post-cardiac arrest syndrome, a pilot randomized controlled trial
Efficacy of CytoSorb®: a systematic review and meta-analysis
Analyse der Ulmer Datenbanken zum internationalen CytoSorb-Register: Dynamik der laborchemischen Leberparameter unter Anwendung des Hämadsorbers CytoSorb bei Patienten der herzchirurgischen Intensivstation
Can the cytokine adsorber CytoSorb® help to mitigate cytokine storm and reduce mortality in critically ill patients? A propensity score matching analysis
Datenerhebung und Auswertung zum internationalen CytoSorb-Register am Universitätsklinikum Ulm
CytoResc – “CytoSorb” Rescue for critically ill patients undergoing the COVID-19 Cytokine Storm: A structured summary of a study protocol for a randomized controlled trial
Prospektive Observationsstudie zur Anwendung von CytoSorb® bei Intensivpatienten mit akutem Leberversagen
Hemoadsorption by CytoSorb in septic patients: a case series
No clinically relevant removal of meropenem by cytokine adsorber CytoSorb® in critically ill patients with sepsis or septic shock
Cytokine clearance with CytoSorb® during cardiac surgery: a pilot randomized controlled trial
Hemoadsorption with CytoSorb® and the early course of linezolid plasma concentration during septic shock
CytoSorb hemoperfusion markedly attenuates circulating cytokine concentrations during systemic inflammation in humans in vivo
Cytokine hemoadsorption with CytoSorb® in post-cardiac arrest syndrome, a pilot randomized controlled trial
Efficacy of CytoSorb®: a systematic review and meta-analysis
Analyse der Ulmer Datenbanken zum internationalen CytoSorb-Register: Dynamik der laborchemischen Leberparameter unter Anwendung des Hämadsorbers CytoSorb bei Patienten der herzchirurgischen Intensivstation
Can the cytokine adsorber CytoSorb® help to mitigate cytokine storm and reduce mortality in critically ill patients? A propensity score matching analysis
Datenerhebung und Auswertung zum internationalen CytoSorb-Register am Universitätsklinikum Ulm
CytoResc – “CytoSorb” Rescue for critically ill patients undergoing the COVID-19 Cytokine Storm: A structured summary of a study protocol for a randomized controlled trial